戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ive immunity that occurs in humans following influenza immunization.
2 ne the overall impact of universal childhood influenza immunization.
3 ococcal vaccine and the initiation of annual influenza immunization.
4 on, DC, who answered a survey question about influenza immunization.
5 the established benefits of current seasonal influenza immunizations.
6 .1) person-years, with increases in rates of influenza immunization (5.9 percentage points [pp]; 95%
7 strongly associated with poor Ab response to influenza immunization, a functional consequence of impa
8 For every 1000 beneficiaries, there were 515 influenza immunizations among whites and 313 among black
9 ith a goal of improving the overall rates of influenza immunization and an eye toward the anticipated
10 ignificant association between maternal H1N1 influenza immunization and LBW or SGA.
11 f aspirin after acute myocardial infarction, influenza immunization), and access to care (for example
12                      However, the benefit of influenza immunization as a preventive measure for PD re
13 ation at midlife and 578 235 did not receive influenza immunization at midlife .
14 0 females [56.6%]), of whom 612 974 received influenza immunization at midlife and 578 235 did not re
15                                              Influenza immunization at midlife vs lack thereof was no
16 sess the risk of incident PD associated with influenza immunization at midlife vs no influenza immuni
17                 This cohort study found that influenza immunization at midlife was not associated wit
18 ween 40 and 50 years of age (hereafter, with influenza immunization at midlife) from 1995 to 2017 and
19 nd unvaccinated controls (hereafter, without influenza immunization at midlife) matched 1:1 on age, s
20 with influenza immunization at midlife vs no influenza immunization at midlife.
21 g evidence of the fetal benefits of maternal influenza immunization by calculating the sample sizes n
22 s cases were reported after pneumococcal and influenza immunization campaigns.
23                                     Maternal influenza immunization can reduce influenza-attributable
24                                     Seasonal influenza immunization continues to be promoted for all
25 tial vaccination strategy where heterologous influenza immunization could be used for increasing the
26 priate use of antiviral agents and improving influenza immunization coverage for all ages continue to
27 These results support the safety of seasonal influenza immunization during pregnancy and suggest a pr
28                                              Influenza immunization during pregnancy provides protect
29          These results indicate that routine influenza immunization efforts should be closely tailore
30    We report the immunogenicity of trivalent influenza immunization in 29 pregnant women compared wit
31 g double-dose hepatitis B vaccine, timing of influenza immunization in patients on biologics, pneumoc
32 sing its capacity to enhance the efficacy of influenza immunization in young infants.
33                              Although annual influenza immunization is recommended for adults aged >/
34                                       Yearly influenza immunization is recommended for immunocompromi
35                                       Annual influenza immunization is recommended for people with ch
36 ve targeting of these populations for annual influenza immunization is warranted.
37                                     Maternal influenza immunization may impact infant acquisition of
38                                     Maternal influenza immunization may prevent these adverse infant
39  A few studies show adequate responses after influenza immunization; no studies examined the season-l
40 on and the gestational age at which maternal influenza immunization occurred.
41 ization Practices has recommended initiating influenza immunization of children as young as 6 months
42 ns and research findings on universal annual influenza immunization of children.
43                                              Influenza immunization of pregnant women protects their
44                                              Influenza immunization of women during pregnancy protect
45 sal effect of maternal influenza illness and influenza immunization on fetal health are evaluated are
46                                    The Swine Influenza Immunization Program began in January 1976 wit
47             Drawing from the ill-fated swine influenza immunization program of 1976, this article out
48                In the context of broad-based influenza immunization programs (targeted or universal),
49                                              Influenza immunization programs aim to reduce the risk a
50 l cavities of pigs vaccinated with different influenza immunization regimens after being infected sim
51                           We analyzed linked influenza immunization registry and laboratory reporting
52 ral nature of influenza illness seasonality, influenza immunization schedules, and gestation itself.
53 nvestigations of fetal benefit from maternal influenza immunization should only be undertaken when in
54 ntial area, population subgroup, parity, and influenza immunization status.
55 ic status, population subgroup, and maternal influenza immunization status.
56 itude of fetal benefit conferred by maternal influenza immunization, studies in which investigators h
57                                  The rate of influenza immunization was 55.4% for patients who receiv
58 and American College of Cardiology recommend influenza immunization with inactivated vaccine (adminis